Picard Medical, Inc. (PMI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Picard Medical, Inc. reported revenue of $4.94M, up 12.5% from the prior year. The company ran a net loss, with a net margin of -546.6% and a gross margin of -4.1%. It held $22.55M in total assets against $18.76M in total liabilities.
Key ratios (FY2025)
-4.1%
Gross margin
-268.4%
Operating margin
-546.6%
Net margin
-712.6%
Return on equity
+12.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $4.94M | $4.39M | — |
| Cost of Revenue | $5.14M | $4.50M | — |
| Gross Profit | -$204.0K | -$112.0K | — |
| Operating Income | -$13.26M | -$13.71M | — |
| Net Income | -$27.00M | -$21.05M | — |
| EPS (Diluted) | $-0.75 | $-2.99 | — |
| Total Assets | $22.55M | $12.11M | — |
| Total Liabilities | $18.76M | $35.84M | — |
| Shareholders' Equity | $3.79M | -$44.00M | -$23.82M |
| Cash & Equivalents | $7.45M | $96.0K | — |
| Operating Cash Flow | -$15.67M | -$11.87M | — |
| Shares Outstanding | 73.70M | 7.94M | — |